| GILD |
Gilead Sciences, Inc. |
129.85B |
5.36% |
|
|
|
|
|
104.16 |
-2.23% |
38.50% |
61.83% |
|---|
| UTHR |
United Therapeutics Corporation |
13.38B |
5.03% |
|
|
|
|
|
297.97 |
-1.69% |
35.09% |
74.12% |
|---|
| NTRA |
Natera, Inc. |
20.54B |
5.02% |
|
|
|
|
|
151.53 |
0.40% |
53.42% |
51.10% |
|---|
| BIIB |
Biogen Inc. |
17.84B |
4.91% |
|
|
|
|
|
121.85 |
0.64% |
46.34% |
53.16% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
62.34B |
4.90% |
|
|
|
|
|
582.91 |
-2.65% |
49.81% |
76.60% |
|---|
| INCY |
Incyte Corporation |
12.04B |
4.85% |
|
|
|
|
|
62.22 |
-0.70% |
42.37% |
60.45% |
|---|
| ILMN |
Illumina, Inc. |
12.15B |
4.85% |
|
|
|
|
|
76.76 |
-1.09% |
63.17% |
71.43% |
|---|
| AMGN |
Amgen Inc. |
152.74B |
4.60% |
|
|
|
|
|
284.10 |
-2.35% |
41.20% |
56.98% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
10.70B |
3.08% |
|
|
|
|
|
108.11 |
0.39% |
34.71% |
54.96% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.85B |
2.98% |
|
|
|
|
|
8.87 |
0.17% |
50.70% |
55.74% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
6.19B |
2.98% |
|
|
|
|
|
62.96 |
0.90% |
72.06% |
35.85% |
|---|
| EXAS |
Exact Sciences Corporation |
8.70B |
2.93% |
|
|
|
|
|
46.82 |
2.57% |
63.70% |
61.49% |
|---|
| QGEN |
Qiagen N.V. |
9.12B |
2.92% |
|
|
|
|
|
42.22 |
-1.24% |
48.39% |
44.58% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.11B |
2.89% |
|
|
|
|
|
63.14 |
-0.86% |
33.04% |
54.68% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.43B |
2.88% |
|
|
|
|
|
14.56 |
-0.31% |
52.38% |
77.59% |
|---|
| MNKD |
MannKind Corporation |
1.50B |
2.85% |
|
|
|
|
|
4.94 |
-2.08% |
234.87% |
55.39% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
2.97B |
2.85% |
|
|
|
|
|
24.32 |
0.12% |
42.34% |
40.92% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.52B |
2.83% |
|
|
|
|
|
60.91 |
-0.84% |
37.56% |
42.67% |
|---|
| TECH |
Bio-Techne Corporation |
7.87B |
2.76% |
|
|
|
|
|
49.78 |
-1.13% |
40.49% |
59.36% |
|---|
| VCYT |
Veracyte, Inc. |
2.33B |
2.74% |
|
|
|
|
|
29.83 |
-2.20% |
62.23% |
55.17% |
|---|
| RPRX |
Royalty Pharma plc |
14.03B |
2.71% |
|
|
|
|
|
32.37 |
-1.37% |
31.94% |
48.25% |
|---|
| BPMC |
Blueprint Medicines Corporation |
6.34B |
2.68% |
|
|
|
|
|
98.17 |
9.68% |
66.68% |
54.00% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
860.17M |
2.66% |
|
|
|
|
|
26.77 |
-0.83% |
55.89% |
42.38% |
|---|
| TGTX |
TG Therapeutics, Inc. |
7.32B |
2.64% |
|
|
|
|
|
46.12 |
1.34% |
80.37% |
75.97% |
|---|
| XNCR |
Xencor, Inc. |
770.22M |
2.62% |
|
|
|
|
|
10.83 |
-1.77% |
81.40% |
44.47% |
|---|
| EXEL |
Exelixis, Inc. |
10.73B |
2.61% |
|
|
|
|
|
38.93 |
-0.56% |
35.76% |
41.53% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
5.43B |
2.50% |
|
|
|
|
|
111.34 |
-0.85% |
49.12% |
29.52% |
|---|
| CDNA |
CareDx, Inc |
843.68M |
2.46% |
|
|
|
|
|
15.18 |
-10.10% |
110.71% |
57.87% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.77B |
2.41% |
|
|
|
|
|
45.07 |
-1.64% |
68.70% |
22.08% |
|---|
| MYGN |
Myriad Genetics, Inc. |
643.82M |
2.40% |
|
|
|
|
|
6.99 |
-5.74% |
60.35% |
68.76% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.08% |
|
|
|
|
|
|
|
|
|
|---|